Aren J. van Loon

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial

Corine M. Koopmans, Denise Bijlenga, Henk Groen et al. · The Lancet · 2009 · 774 citations

Family Medicine, Hypertension, Gestational Hypertension +11

Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial

David P. van der Ham, Jantien L. van der Heyden, Brent C. Opmeer et al. · American Journal of Obstetrics and Gynecology · 2012 · 194 citations · Full text

Ppromexil-2 Trial, Preterm Premature Rupture Of Membranes, Surgery +1

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial

Kim Broekhuijsen, Gert-Jan van Baaren, Maria G. van Pampus et al. · The Lancet · 2015 · 191 citations

Hypertension, Gestational Hypertension, Pregnancy Disorders +11

Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial

Daphne N. Voormolen, J. Hans DeVries, Rieneke M. E. Sanson et al. · Diabetes Obesity and Metabolism · 2018 · 143 citations · Full text

Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): a multicentre randomised controlled non-inferiority trial

Mieke Ten Eikelder, Katrien Oude Rengerink, Marta Jozwiak et al. · The Lancet · 2016 · 121 citations

Patient Safety, Oral Misoprostol, Gynecology +6